Saturday 17 October 2026
Export NSYS’s income statement to Excel — free account
Nortech Systems Incorporated
NSYS Healthcare Medical Devices
In the quarter to June 2026, revenue grew 9.34%, EPS fell 8.33%, free cash flow fell 1,567.2% and total debt fell 79.0%, each against the same quarter a year earlier.
10.32
0.19
−1.81%
Follow NSYS
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
377.00 | 0.00 | 50.71 | 0.00 | 0.00 | 3.86 | 15.83 | 4.04 | 0.00 | 0.00 |
Piotroski F-Score |
6 | 5 | 7 | 5 | 5 | 6 | 6 | 6 | 1 | 5 |
P/S ratio |
0.09 | 0.10 | 0.08 | 0.11 | 0.18 | 0.24 | 0.24 | 0.20 | 0.22 | 0.17 |
Altman Z-Score |
2.91 | 2.83 | 2.65 | 2.60 | 2.58 | 2.96 | 3.32 | 3.37 | 3.10 | 2.79 |
P/FCF ratio |
6.55 | 19.64 | 9.07 | 54.53 | 2.78 | 0.00 | 10.76 | 69.18 | 0.00 | 8.25 |
Altman Z″-Score (non-manufacturers) |
3.42 | 3.21 | 3.30 | 3.00 | 3.03 | 4.25 | 4.33 | 5.09 | 4.76 | 4.24 |
Beneish M-Score |
(2.90) | (2.86) | (2.59) | (2.20) | (2.70) | (1.58) | (2.86) | (2.10) | (2.42) | (2.62) |
P/Operating CF |
6.24 | 56.36 | (79.64) | 10.55 | 13.04 | (16.34) | 7.24 | (66.99) | 35.75 | 3.68 |
P/B ratio |
0.47 | 0.55 | 0.46 | 0.66 | 1.03 | 1.07 | 1.15 | 0.79 | 0.84 | 0.60 |
Price to Tangible BV |
0.61 | 0.70 | 0.56 | 0.81 | 1.10 | 1.09 | 1.16 | 0.79 | 0.84 | 0.60 |
EV/Sales |
0.20 | 0.22 | 0.20 | 0.24 | 0.26 | 0.32 | 0.29 | 0.24 | 0.29 | 0.18 |
EV/EBITDA |
8.14 | 11.71 | 6.76 | 11.24 | 6.84 | 8.73 | 6.61 | 4.17 | 24.48 | 9.28 |
EV/Operating CF |
6.75 | 31.10 | 9.50 | 27.56 | 19.84 | (8.12) | 7.10 | 18.85 | (16.79) | 7.66 |
EV/FCF |
15.09 | 45.74 | 22.04 | 115.46 | 3.94 | (7.00) | 12.95 | 83.58 | (10.50) | 8.40 |
Quick Ratio |
0.88 | 1.01 | 0.85 | 0.86 | 0.98 | 0.99 | 0.80 | 0.79 | 0.74 | 0.63 |
Current Ratio |
1.94 | 2.09 | 1.84 | 1.95 | 2.10 | 2.32 | 2.08 | 2.21 | 2.58 | 1.88 |
Net Debt/EBITDA |
4.61 | 6.68 | 3.98 | 5.93 | 2.02 | 1.81 | 0.85 | 0.54 | 5.20 | (0.45) |
Debt/Assets |
24.81% | 28.95% | 24.38% | 24.69% | 20.04% | 14.72% | 10.67% | 8.02% | 12.35% | 0.87% |
Debt/Equity |
0.62 | 0.76 | 0.69 | 0.76 | 0.62 | 0.38 | 0.26 | 0.17 | 0.26 | 0.02 |
Asset Turnover |
2.08 | 2.09 | 2.02 | 1.92 | 1.75 | 1.85 | 1.96 | 1.93 | 1.74 | 1.64 |
Operating CF/Net income |
80.69 | (0.33) | 14.72 | (0.81) | (0.88) | (0.63) | 2.69 | 0.26 | 1.74 | (10.88) |
Capex/Depreciation |
(0.85) | (0.08) | (0.63) | (0.34) | 1.20 | (0.37) | (1.26) | (0.63) | (0.73) | (0.12) |
Interest Coverage |
1.15 | (2.02) | 1.65 | 0.21 | (0.99) | 5.28 | 9.46 | 12.22 | (0.26) | 1.01 |
| 0.20% | (11.75%) | 0.82% | (6.05%) | (8.10%) | 32.28% | 7.49% | 21.85% | (3.76%) | (0.74%) | |
| 0.08% | (4.55%) | 0.30% | (2.02%) | (2.60%) | 11.47% | 2.94% | 9.50% | (1.76%) | (0.35%) | |
ROIC |
1.11% | (2.32%) | 2.25% | 0.41% | (1.44%) | 4.21% | 7.36% | 9.37% | (0.29%) | 1.82% |
Return on Tangible Assets |
0.15% | (8.18%) | 0.53% | (4.01%) | (5.54%) | 20.27% | 5.76% | 17.75% | (3.23%) | (0.80%) |
Average Days of Receivables |
54.83 | 56.59 | 64.69 | 58.23 | 54.78 | 62.62 | 50.69 | 50.50 | 42.37 | 52.42 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.42% | 1.09% | 0.86% | 0.93% | 0.99% |
Selling, General and Administrative Expense of Revenue |
11.33% | 11.42% | 10.64% | 10.62% | 11.26% | 10.73% | 11.29% | 11.45% | 11.83% | 13.17% |
Intangible Assets out of Total Assets |
0.09 | 0.08 | 0.07 | 0.06 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.04% | 0.11% | 0.22% | 0.17% | 0.22% | 0.25% | 0.30% | 0.36% | 0.42% |
Graham Net Nets |
0.61 | 0.51 | 0.73 | 0.14 | 0.11 | 0.39 | 0.42 | 0.69 | 0.60 | 0.91 |
Graham Number |
1.34 | 0.00 | 3.49 | 0.00 | 0.00 | 24.19 | 13.23 | 26.98 | 0.00 | 0.00 |
Earnings Yield |
0.27% | (22.85%) | 1.97% | (9.45%) | (8.37%) | 25.89% | 6.32% | 24.75% | (4.57%) | (1.21%) |
Free Cash Flow Yield |
15.27% | 5.09% | 11.03% | 1.83% | 36.01% | (19.11%) | 9.29% | 1.45% | (12.70%) | 12.12% |
Revenue per Share |
42.45 | 40.91 | 42.11 | 43.65 | 39.17 | 43.22 | 49.95 | 51.19 | 46.51 | 42.62 |
Operating CF per Share |
1.29 | 0.29 | 0.91 | 0.37 | 0.51 | (1.70) | 2.01 | 0.65 | (0.82) | 0.99 |
Capex per Share |
(0.71) | (0.09) | (0.52) | (0.28) | 2.07 | (0.27) | (0.90) | (0.47) | (0.46) | (0.06) |
Free Cash Flow per Share |
0.58 | 0.20 | 0.39 | 0.09 | 2.58 | (1.98) | 1.11 | 0.18 | (1.28) | 0.93 |
Cash per Share |
0.10 | 0.28 | 0.35 | 0.25 | 1.34 | 0.83 | 0.92 | 0.62 | 0.33 | 0.60 |
Shareholders Equity per Share |
8.12 | 7.22 | 7.83 | 7.50 | 7.04 | 9.80 | 10.46 | 12.98 | 12.34 | 12.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.12 | 7.22 | 7.83 | 7.50 | 7.04 | 9.80 | 10.46 | 12.98 | 12.34 | 12.44 |
Free Cash Flow |
1.58 | 0.55 | 1.05 | 0.24 | 6.86 | (5.27) | 2.98 | 0.49 | (3.51) | 2.59 |
Working Capital |
19.18 | 19.72 | 20.96 | 21.05 | 21.50 | 29.47 | 28.46 | 32.21 | 33.89 | 26.31 |
Capital Expenditures |
(1.95) | (0.26) | (1.39) | (0.76) | 5.50 | (0.73) | (2.43) | (1.28) | (1.26) | (0.16) |
Net Current Asset Value |
6.29 | 5.51 | 6.99 | 1.85 | 2.12 | 10.79 | 13.40 | 19.01 | 16.89 | 18.78 |
EV/EBIT |
37.63 | 0.00 | 18.60 | 122.68 | 0.00 | 16.23 | 9.86 | 5.60 | 0.00 | 21.54 |
Capex to Sales |
0.02 | 0.00 | 0.01 | 0.01 | (0.05) | 0.01 | 0.02 | 0.01 | 0.01 | 0.00 |
Price to Operating Income |
16.33 | 0.00 | 7.65 | 57.94 | 0.00 | 12.14 | 8.20 | 4.64 | 0.00 | 21.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.34 | 0.22 | 0.23 | 0.71 | 0.33 | 0.30 | 0.31 | 0.28 | 0.25 |
Cash ROIC |
4.35% | 1.54% | 2.88% | 0.67% | 20.29% | (13.79%) | 7.84% | 1.13% | (8.01%) | 7.02% |
Accounts Receivable Turnover |
6.43 | 6.43 | 6.04 | 6.02 | 6.09 | 6.51 | 6.99 | 7.35 | 7.50 | 7.43 |
Accounts Payable Turnover |
7.65 | 7.85 | 6.71 | 6.45 | 7.48 | 8.29 | 8.26 | 7.57 | 8.10 | 8.23 |
Inventory Turnover |
5.03 | 5.12 | 5.63 | 6.63 | 6.70 | 5.96 | 5.43 | 5.27 | 5.15 | 4.74 |
Average Days of Payables |
49.10 | 42.61 | 66.18 | 49.30 | 43.44 | 46.72 | 47.51 | 50.01 | 37.94 | 46.59 |
Days of Inventory on Hand |
73.35 | 67.48 | 62.03 | 50.23 | 53.79 | 71.43 | 72.07 | 68.02 | 70.89 | 75.27 |
Average Receivables |
18.13 | 17.47 | 18.76 | 19.33 | 17.09 | 17.69 | 19.19 | 18.95 | 17.08 | 15.94 |
Average Payables |
13.43 | 12.76 | 14.92 | 16.08 | 12.63 | 11.97 | 13.75 | 15.36 | 13.75 | 12.20 |
Average Inventory |
20.42 | 19.59 | 17.77 | 15.64 | 14.10 | 16.68 | 20.94 | 22.05 | 21.65 | 21.17 |
Average Assets |
56.04 | 53.80 | 56.02 | 60.69 | 59.52 | 62.36 | 68.32 | 72.33 | 73.78 | 72.18 |
Average Common Equity |
22.04 | 20.82 | 20.21 | 20.28 | 19.10 | 22.16 | 26.85 | 31.46 | 34.42 | 34.03 |
Columns are period end dates